A431, OVCAR3, BxPC3 and HT-29 (clone mAb2)-Amino-PEG6-C2-MMAD ADC (CAT#: ADC-294CL)
This ADC product is composed of an anti-A431, OVCAR3, BxPC3 and HT-29 antibody (clone mAb2) conjugated via Amino-PEG6-C2 linker to MMAD(mAb2-N297Q-Amino-PEG6-C2-MMAD).
Specific Inquiry
Specifications
- Antibody Overview
- mAb2 (a Chimeric IgG1 Antibody) N297Q
- Clone
- mAb2
- Antibody Isotype
- IgG1
- Linker
- Amino-PEG6-C2
- Drug
- MMAD (monomethyl auristatin D)
- Drug Class/Description
- Class: Auristatin
Description: Auristatins are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone mAb2"
Customer Reviews and Q&As
There are currently no Customer reviews or questions for ADC-294CL. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: WB, Neut, ELISA, IF, IP, FuncS, FC
Application: ELISA, FC, IP, FuncS, IF, Neut, WB
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
![Figure 2 Anti-Human CD19 Recombinant Antibody Fab Fragment [TAB-1611CL-F(E)] in HPLC](https://img.creativebiolabs.net/productimages/COA-TAB-1611CL-F(E)-2.png)
Application: Depletion, FuncS
Application: WB, ELISA, FC, IHC, IF, IP
Application: Neut, ELISA, IF, IP, FuncS, FC
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
